Consensus for FY25 revenue is $11.24B. For 2025, the company now anticipates total revenue of $12.0B-$12.2B, a Medical Loss Ratio of 86.0% to 87.0%, a SG&A Expense Ratio of 17.1% to 17.6%, and a loss from operations of (300M)-(200M). The company expects an adjusted EBITDA loss of approximately $120M less than the loss from operations, it noted.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OSCR:
- Oscar Health raises FY25 revenue view to $12.0B-$12.2B from $11.2B-$11.3B
- Oscar Health sees Q2 net loss $228M
- Oscar Health downgraded to Sell from Neutral at UBS
- Oscar Health downgraded to Neutral from Overweight at Piper Sandler
- Option traders moderately bearish in Oscar Health with shares down 4.67%